We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.05%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$89.7B
AUM Growth
+$10.5B
Cap. Flow
+$5.02B
Cap. Flow %
5.59%
Top 10 Hldgs %
23.67%
Holding
8,070
New
1,409
Increased
2,466
Reduced
2,668
Closed
1,304

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$332M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$289M
3
INTU icon
Intuit
INTU
+$241M
4
RTN
Raytheon Company
RTN
+$200M
5
PEP icon
PepsiCo
PEP
+$197M

Sector Composition

Rank Sector Weight
1 Technology 6.26%
2 Consumer Discretionary 5.39%
3 Financials 4.9%
4 Healthcare 4.63%
5 Industrials 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UAMY icon
6551
United States Antimony
UAMY
$920M
$9K ﹤0.01%
44,838
-112,270
-71% -$28.3K
TMBR
6552
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$9K ﹤0.01%
1
FNCX
6553
DELISTED
Function(x) Inc.
FNCX
$9K ﹤0.01%
1,616
-208
-11% -$1.35K
WGBS
6554
DELISTED
WaferGen Bio-systems, Inc.
WGBS
$9K ﹤0.01%
2,292
-16,232
-88% -$60.5K
PLX icon
6555
PUT
Protalix BioTherapeutics
PLX
$197M
$8K ﹤0.01%
1,200
-2,000
-63% -$16K
XOMA
6556
CALL
DELISTED
Xoma
XOMA
$8K ﹤0.01%
710
-395
-36% -$5.66K
JXG
6557
JX Luxventure
JXG
$85.5M
$8K ﹤0.01%
+2
New +$5.79K
CETC
6558
DELISTED
Hongli Clean Energy Technologies Corp. Common Stock
CETC
$8K ﹤0.01%
+2,884
New +$11.4K
TWER
6559
DELISTED
Towerstream Corporation Common Stock
TWER
$8K ﹤0.01%
2,425
+262
+12% +$1.01K
ARP
6560
CALL
DELISTED
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
$8K ﹤0.01%
15,600
-12,300
-44% -$6.34K
GEVO icon
6561
PUT
Gevo
GEVO
$351M
$7K ﹤0.01%
+29
New +$4.38K
PLX icon
6562
Protalix BioTherapeutics
PLX
$197M
$7K ﹤0.01%
1,068
-1,586
-60% -$12.7K
GSS
6563
PUT
DELISTED
Golden Star Resources Ltd.
GSS
$7K ﹤0.01%
+2,260
New +$6.92K
NAVB
6564
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$7K ﹤0.01%
686
+72
+12% +$1.41K
MTL.PR
6565
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$7K ﹤0.01%
31,343
-51,906
-62% -$12.9K
LSTA icon
6566
Lisata Therapeutics
LSTA
$9.74M
$6K ﹤0.01%
72
-133
-65% -$12.2K
TGB
6567
CALL
Trekor Metals
TGB
$3.02B
$6K ﹤0.01%
+12,000
New +$6.34K
GLRI
6568
DELISTED
GLORI ENERGY INC COMMON STOCK
GLRI
$6K ﹤0.01%
28,595
-202,745
-88% -$44.5K
IPDN icon
6569
Professional Diversity Network
IPDN
$5.49M
$5K ﹤0.01%
77
-320
-81% -$26K
AIM
6570
AIM ImmunoTech
AIM
$7.51M
$5K ﹤0.01%
1
-3
-75% -$19.7K
NSPR icon
6571
InspireMD
NSPR
$33.8M
0
CDMO
6572
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4K ﹤0.01%
1,514
+57
+4% +$159
SAEX
6573
DELISTED
SAExploration Holdings, Inc.
SAEX
$4K ﹤0.01%
14
+6
+75% +$8.26K
WGA
6574
DELISTED
AG&E Holdings Inc
WGA
$4K ﹤0.01%
14,317
-32,512
-69% -$10.8K
PALI icon
6575
Palisade Bio
PALI
$363M
0

Similar funds

Citadel Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Citadel Advisors held 8,070 positions worth $89.7B, up 13% from $79.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $5.02B of net new capital in Q2 2016, opening 1,409 new positions and adding to 2,466 existing holdings. Its largest new stake was United Airlines: 4,297,394 shares worth $176M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 5.3% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Home Depot, an estimated $332M trimmed.

  • Citadel Advisors's largest Q2 2016 buy was United Airlines: 4,297,394 shares worth $176M.
  • Citadel Advisors added most to Fidelity National Information Services in Q2 2016, an estimated $361M increase.
  • Citadel Advisors's biggest Q2 2016 reduction was Home Depot, cutting an estimated $332M.
  • Citadel Advisors fully exited Alphabet (Google) Class A in Q2 2016, selling an estimated $289M.
  • Citadel Advisors's ten largest holdings make up 24% of its $89.7B portfolio in Q2 2016.
  • Citadel Advisors opened 1,409 new positions and closed 1,304 in Q2 2016.
  • Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $89.7B.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.